Vanda Pharmaceuticals
VNDA
VNDA
133 hedge funds and large institutions have $633M invested in Vanda Pharmaceuticals in 2017 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 53 increasing their positions, 46 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
133
Holders Change
-3
Holders Change %
-2.21%
% of All Funds
3.32%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.1%
New
13
Increased
53
Reduced
46
Closed
15
Calls
$1.89M
Puts
$497K
Net Calls
+$1.4M
Net Calls Change
+$1.3M
Top Buyers
| 1 |
O
1
OrbiMed
New York
|
$15.8M |
| 2 |
SCM
2
Stonepine Capital Management
Bend,
Oregon
|
$11.2M |
| 3 |
3
BlackRock
New York
|
$72.8M |
| 4 |
AC
4
Armistice Capital
New York
|
$33.6M |
| 5 |
ACA
5
Avoro Capital Advisors
New York
|
$14.7M |
